To show a violation:
The pharmacy benefits manager has copped to artificially inflating the list price of drugs by using unfair rebating practices.
Kevin Kinsella3 min read
The FTC said the absence of Signal messages from Amazon discussing substantive business issues relevant to the antitrust case against the company meant those messaged had "disappeared."
Julie DiMauro2 min read
In many ways, 2025 found the healthcare sector at a crossroads, with compliance officers holding their heads.
Kevin Kinsella4 min read
Against a backdrop of uncertain times for healthcare M&A, we spoke to Barry Posner, partner at Kudman Trachten Aloe Posner LLP.
Julie DiMauro31 min listen
Critics have long expressed concerns regarding the two firms' influence on corporate governance.
Alexander Barzacanos2 min read
Our in-brief roundup of notable stories from the last week.
GRIP2 min read
The regulator claims that the companies' agreement to effectively eliminate Redfin represents an illegal acquisition and would destroy rental advertising competition.
Catherine Ollinger1 min read
The Federal Trade Commission sent formal letters to major healthcare employers and staffing firms urging them to review restrictive employment agreements.
Vlada Gurvich3 min read